» Articles » PMID: 34513083

WNK3 Promotes the Invasiveness of Glioma Cell Lines Under Hypoxia by Inducing the Epithelial-to-mesenchymal Transition

Overview
Journal Transl Neurosci
Specialty Neurology
Date 2021 Sep 13
PMID 34513083
Citations 2
Authors
Affiliations
Soon will be listed here.
Abstract

Background: The primary features of malignant glioma include high rates of mortality and recurrence, uncontrollable invasiveness, strong angiogenesis, and widespread hypoxia. The hypoxic microenvironment is an important factor affecting the malignant progression of glioma. However, the molecular mechanisms underlying glioma adaption in hypoxic microenvironments are poorly understood.

Objective: The work presented in this paper focuses on the role of WNK3 gene in glioma invasion under hypoxic conditions. Furthermore, we aim to explore its role in epithelial-to-mesenchymal transition (EMT).

Methods: ShRNA targeting WNK3 transfection was used to knockdown the WNK3 expression in U87 cells. We used western blot analysis to detect the relative expression of proteins in U87 cells. The effect of WNK3 on cell migration was explored using a transwell assay in the U87 cell line. We also evaluated WNK3 expression levels in glioma samples by immunohistochemistry analysis.

Results: WNK3 expression was significantly higher in high-grade (III and IV) gliomas than in low-grade (I and II) gliomas. WNK3 expression was up-regulated in U87 cells when cultured in a hypoxic environment in addition; WNK3 knockdown inhibited the invasion of U87 glioma cells by regulating the EMT, especially under hypoxic conditions.

Conclusion: These findings suggested that WNK3 plays an important role in the hypoxic microenvironment of glioma and might also be a candidate for therapeutic application in the treatment of glioma.

Citing Articles

An update regarding the role of WNK kinases in cancer.

Xiu M, Li L, Li Y, Gao Y Cell Death Dis. 2022; 13(9):795.

PMID: 36123332 PMC: 9485243. DOI: 10.1038/s41419-022-05249-y.


Identification of an Inflammatory Response-Related Gene Signature to Predict Survival and Immune Status in Glioma Patients.

Yan Z, Gao Y, Yu J, Shen Z, Bu X J Immunol Res. 2022; 2022:8972730.

PMID: 35647198 PMC: 9132661. DOI: 10.1155/2022/8972730.

References
1.
Brat D, Castellano-Sanchez A, Hunter S, Pecot M, Cohen C, Hammond E . Pseudopalisades in glioblastoma are hypoxic, express extracellular matrix proteases, and are formed by an actively migrating cell population. Cancer Res. 2004; 64(3):920-7. DOI: 10.1158/0008-5472.can-03-2073. View

2.
Cheng J, Wang L, Wang H, Tang F, Cai W, Sethi G . Insights into Biological Role of LncRNAs in Epithelial-Mesenchymal Transition. Cells. 2019; 8(10). PMC: 6829226. DOI: 10.3390/cells8101178. View

3.
Verissimo F, Jordan P . WNK kinases, a novel protein kinase subfamily in multi-cellular organisms. Oncogene. 2001; 20(39):5562-9. DOI: 10.1038/sj.onc.1204726. View

4.
Persano L, Rampazzo E, Della Puppa A, Pistollato F, Basso G . The three-layer concentric model of glioblastoma: cancer stem cells, microenvironmental regulation, and therapeutic implications. ScientificWorldJournal. 2011; 11:1829-41. PMC: 3217608. DOI: 10.1100/2011/736480. View

5.
Schiffer D, Mellai M, Bovio E, Bisogno I, Casalone C, Annovazzi L . Glioblastoma niches: from the concept to the phenotypical reality. Neurol Sci. 2018; 39(7):1161-1168. DOI: 10.1007/s10072-018-3408-0. View